Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2021-06-11 Board/Management Inform…
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Resignation
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges notifying the resignation of the Chief Financial Officer, which is a change in senior management. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, which pertains to disclosure of material events including management changes. The document does not contain financial data, audit information, or report content. It is an announcement of a management change, not a report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a report or other filing type.
2021-06-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 80% confidence The document is a letter addressed to stock exchanges announcing the availability of a written transcript of a conference call held on May 25, 2021. It references the SEBI regulation for disclosure and provides a link to the transcript on the company's website. The document itself does not contain the transcript but announces its publication. The document length is short (1192 characters), and it explicitly states that the transcript has been uploaded and can be accessed via a link. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Call Transcript (CT) because the content relates to a conference call transcript, but since the transcript is not included, it is an announcement of the transcript. However, the classification options do not have a separate category for transcript announcements, so the best fit is Call Transcript (CT) with moderate confidence, or Regulatory Filings (RNS) as fallback. Given the document's nature, the best classification is Call Transcript (CT) with confidence 0.8.
2021-06-04 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of audited financial results for the quarter and financial year ended March 31, 2021. The letter states that the audited financial results have been published in newspapers on May 26, 2021. The document length is short (1068 characters) and it primarily serves as an announcement of the publication of the audited financial results rather than containing the full financial report itself. According to the 'Menu vs Meal' rule, such a short document announcing the publication of a report should be classified as a Report Publication Announcement (RPA), not as the full Annual Report or Interim Report. Therefore, the appropriate classification is RPA with high confidence.
2021-05-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of a conference call held on May 25, 2021, to discuss Q4FY21 results and future outlook. It mentions that the audio recording link has been uploaded and that a written transcript will be submitted later. The document does not contain the transcript itself or detailed financial data, but rather an announcement about the availability of the conference call recording and the forthcoming transcript. Therefore, this is not the actual Call Transcript (CT) but an announcement related to it. Given the short length (1251 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the conference call recording and transcript submission.
2021-05-25 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India and BSE Limited, disclosing related party transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015. It specifically mentions the half year ended March 31, 2021, and provides details of related party transactions for that period. The document is a regulatory disclosure of related party transactions, which is a compliance filing under SEBI regulations. It is not a full financial report like an Annual Report or Interim Report, nor is it an announcement of voting results or management changes. The document is relatively short (2807 characters) and is a formal disclosure letter with transaction details. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance disclosures that do not fit other specific categories.
2021-05-25 English
Dividend
Annual Report Classification · 95% confidence The document is a detailed filing dated May 25, 2021, addressed to stock exchanges in India, referencing compliance with SEBI (LODR) Regulations, 2015. It announces the approval of audited standalone and consolidated financial results for the fiscal year ended March 31, 2021, including detailed financial statements such as income statements, balance sheets, and cash flow statements. It also includes the auditors' report with an unmodified opinion. The document contains comprehensive financial data for the full fiscal year and quarter, not just a summary or announcement. It also mentions the board's recommendation of a dividend subject to shareholder approval. The presence of full audited financial results and the auditor's report indicates this is a formal annual financial report. Therefore, this document fits the definition of an Annual Report (10-K equivalent) rather than just an earnings release or audit report alone. The length and detail confirm it is not a brief announcement or certification but a full report. FY 2021
2021-05-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.